$0.78
0[0.00%]
At close: Apr 24
$0.78
0[0.00%]
PreMarket: 4:02PM EDT
AlloVir
(NASDAQ:ALVR)Latest News for AlloVir Stock (NASDAQ:ALVR)
AlloVir Stock (NASDAQ: ALVR)
Categories: All
Tuesday, January 16, 2024
Thursday, January 04, 2024
Tuesday, December 26, 2023
Monday, December 25, 2023
Friday, December 22, 2023
- Dow Edges Lower; Nike Sales Miss EstimatesAvi Kapoor - Dec 22, 2023, 2:47PM
- Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Dec 22, 2023, 1:28PM
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Dec 22, 2023, 12:31PM
- Gold Moves Higher; US Consumer Sentiment Improves In DecemberAvi Kapoor - Dec 22, 2023, 12:18PM
- Leerink Partners Downgrades AlloVir to Market Perform, Announces $1 Price TargetBenzinga Newsdesk - Dec 22, 2023, 11:50AM
- Dow Rises 50 Points; Fed's Preferred Inflation Gauge Cools In NovemberAvi Kapoor - Dec 22, 2023, 9:40AM
- Piper Sandler Downgrades AlloVir to Neutral, Lowers Price Target to $1.5Benzinga Newsdesk - Dec 22, 2023, 9:32AM
- JP Morgan Downgrades AlloVir to UnderweightBenzinga Newsdesk - Dec 22, 2023, 9:29AM
- Why Is Penny Stock Cell Therapy Focused AlloVir Stock Plummeting Today?Vandana Singh - Dec 22, 2023, 9:23AM
- AlloVir shares are trading lower after the company announced it will discontinue its three Phase 3 posoleucel studies following separate, pre-planned DSMB futility analyses concluding the studies were unlikely to meet their primary endpoints.Benzinga Newsdesk - Dec 22, 2023, 8:41AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Dec 22, 2023, 8:07AM
- AlloVir Says It Will Discontinue Its Three Phase 3 Posoleucel Studies Following Separate, Pre-planned DSMB Futility Analyses Concluding Studies Were Unlikely To Meet Primary EndpointsBenzinga Newsdesk - Dec 22, 2023, 7:09AM
Tuesday, October 24, 2023
Tuesday, September 19, 2023
Friday, September 15, 2023
Tuesday, August 29, 2023
Monday, August 21, 2023
Friday, August 18, 2023
- AlloVir's RSV Therapy Is Underappreciated Gem, BofA Comments On Future PotentialShivani Kumaresan - Aug 18, 2023, 2:00PM
- AlloVir shares are trading higher after B of A Securities initiated coverage on the stock with a Buy rating and announced a $17 price target.Benzinga Newsdesk - Aug 18, 2023, 12:51PM
- Benzinga's Top Ratings Upgrades, Downgrades For August 18, 2023Benzinga Insights - Aug 18, 2023, 11:00AM
- B of A Securities Initiates Coverage On AlloVir with Buy Rating, Announces Price Target of $17Benzinga Newsdesk - Aug 18, 2023, 6:57AM
Monday, August 14, 2023
Monday, August 07, 2023
Thursday, August 03, 2023
Monday, July 31, 2023
Thursday, June 29, 2023
Monday, June 26, 2023
Thursday, June 22, 2023
- Crude Oil Down Over 4%; Innovative Eyewear Shares PlummetLisa Levin - Jun 22, 2023, 2:55PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Jun 22, 2023, 1:38PM
- Why Avid Bioservices Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Jun 22, 2023, 1:09PM
- Nasdaq Rises 70 Points; Aeglea BioTherapeutics Shares Spike HigherLisa Levin - Jun 22, 2023, 12:10PM
- US Stocks Lower Following Initial Jobless Claims ReportLisa Levin - Jun 22, 2023, 9:41AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Jun 22, 2023, 9:12AM
- Why AlloVir Stock Is Diving ThursdayAdam Eckert - Jun 22, 2023, 8:53AM
- Why Root Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving PremarketLisa Levin - Jun 22, 2023, 7:51AM
- AlloVir, DigitalOcean And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionLisa Levin - Jun 22, 2023, 6:35AM
- AlloVir shares are trading lower after the company priced a 20 million share offering at $3.75/share.Benzinga Newsdesk - Jun 22, 2023, 5:22AM